Literature DB >> 24157929

Intracellular Nogo-A facilitates initiation of neurite formation in mouse midbrain neurons in vitro.

Z Kurowska1, P Brundin2, M E Schwab3, J-Y Li4.   

Abstract

Nogo-A is a transmembrane protein originally discovered in myelin, produced by postnatal CNS oligodendrocytes. Nogo-A induces growth cone collapse and inhibition of axonal growth in the injured adult CNS. In the intact CNS, Nogo-A functions as a negative regulator of growth and plasticity. Nogo-A is also expressed by certain neurons. Neuronal Nogo-A depresses long-term potentiation in the hippocampus and modulates neurite adhesion and fasciculation during development in mice. Here we show that Nogo-A is present in neurons derived from human midbrain (Lund human mesencephalic (LUHMES) cell line), as well as in embryonic and postnatal mouse midbrain (dopaminergic) neurons. In LUHMES cells, Nogo-A was upregulated threefold upon differentiation and neurite extension. Nogo-A was localized intracellularly in differentiated LUHMES cells. Cultured midbrain (dopaminergic) neurons from Nogo-A knock-out mice exhibited decreased numbers of neurites and branches when compared with neurons from wild-type (WT) mice. However, this phenotype was not observed when the cultures from WT mice were treated with an antibody neutralizing plasma membrane Nogo-A. In vivo, neither the regeneration of nigrostriatal tyrosine hydroxylase fibers, nor the survival of nigral dopaminergic neurons after partial 6-hydroxydopamine lesions was affected by Nogo-A deletion. These results indicate that during maturation of cultured midbrain (dopaminergic) neurons, intracellular Nogo-A supports neurite growth initiation and branch formation.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3,3′-diaminobenzidine; 4′,6-diamidino-2-phenylindole; 6-OHDA; 6-hydroxydopamine; ANOVA; DAB; DAPI; DMEM; Dulbecco’s Modified Eagle Medium; EDTA; FCS; GDNF; Glial cell line-derived neurotrophic factor; HBSS; HRP; Hanks Balanced Salt Solution; KO; LUHMES cells; Lund human nesencephalic cells; Nogo-A; PBS; PBS with 0.3% Triton X-100; PBST; PFA; Parkinson’s disease; RCF; SDS–PAGE; TH; WT; analysis of variance; cell culture; ethylenediaminetetraacetic acid; fetal calf serum; horseradish peroxidase; knock-out; midbrain dopaminergic neurons; neurite growth; paraformaldehyde; phosphate-buffered saline; relative centrifugal force; sodium dodecyl sulfate polyacrylamide gel electrophoresis; tyrosine hydroxylase; wild-type

Mesh:

Substances:

Year:  2013        PMID: 24157929     DOI: 10.1016/j.neuroscience.2013.10.029

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  Upregulation of the zebrafish Nogo-A homologue, Rtn4b, in retinal ganglion cells is functionally involved in axon regeneration.

Authors:  Cornelia Welte; Sarah Engel; Claudia A O Stuermer
Journal:  Neural Dev       Date:  2015-03-20       Impact factor: 3.842

2.  Nogo-A and its functions beyond axonal inhibition: the controversial role of Nogo-A in Parkinson's disease.

Authors:  Stefanie Seiler; Hans R Widmer
Journal:  Neural Regen Res       Date:  2015-08       Impact factor: 5.135

3.  Anti-Nogo-A Immunotherapy Does Not Alter Hippocampal Neurogenesis after Stroke in Adult Rats.

Authors:  Daniel J Shepherd; Shih-Yen Tsai; Timothy E O'Brien; Robert G Farrer; Gwendolyn L Kartje
Journal:  Front Neurosci       Date:  2016-10-18       Impact factor: 4.677

4.  Axonal branching in lateral olfactory tract is promoted by Nogo signaling.

Authors:  Masumi Iketani; Takaakira Yokoyama; Yuji Kurihara; Stephen M Strittmatter; Yoshio Goshima; Nobutaka Kawahara; Kohtaro Takei
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

5.  Antagonization of the Nogo-Receptor 1 Enhances Dopaminergic Fiber Outgrowth of Transplants in a Rat Model of Parkinson's Disease.

Authors:  Stefanie Seiler; Stefano Di Santo; Lukas Andereggen; Hans R Widmer
Journal:  Front Cell Neurosci       Date:  2017-05-26       Impact factor: 5.505

6.  Forebrain NgR1 Overexpression Impairs DA Release Suggesting Synergy of Local and Global Synaptic Plasticity Mechanisms.

Authors:  Emma Arvidsson; Sarolta Gabulya; Alvin Tore Brodin; Tobias Erik Karlsson; Lars Olson
Journal:  Front Synaptic Neurosci       Date:  2020-12-10

Review 7.  The Implication of Reticulons (RTNs) in Neurodegenerative Diseases: From Molecular Mechanisms to Potential Diagnostic and Therapeutic Approaches.

Authors:  Agnieszka Kulczyńska-Przybik; Piotr Mroczko; Maciej Dulewicz; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

8.  Quantification of Neurite Degeneration with Enhanced Accuracy and Efficiency in an In Vitro Model of Parkinson's Disease.

Authors:  Rachel T Clements; Lauren E Fuller; Kyle R Kraemer; Samantha A Radomski; Sarah Hunter-Chang; Wesley C Hall; Alborz A Kalantar; Bradley R Kraemer
Journal:  eNeuro       Date:  2022-03-18

9.  Nogo-A Neutralization Improves Graft Function in a Rat Model of Parkinson's Disease.

Authors:  Stefanie Seiler; Stefano Di Santo; Hans Rudolf Widmer
Journal:  Front Cell Neurosci       Date:  2016-04-05       Impact factor: 5.505

10.  Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.

Authors:  Gian-Carlo Eyer; Stefano Di Santo; Ekkehard Hewer; Lukas Andereggen; Stefanie Seiler; Hans Rudolf Widmer
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.